FDA Drug Application (021897) for VIVITROL by ALKERMES

Back to FDA Applications sponsored by ALKERMES

Application Number021897
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage380MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVIVITROL
Active IngredientNALTREXONE



Back to FDA Applications sponsored by ALKERMES